Newsroom

White & Case advises Alvogen on sale to Lotus Pharmaceutical

White & Case advises Neopharmed Gentili on acquisition of ORLADEYO®’s European business from BioCryst Pharmaceuticals

White & Case advises Helix Acquisition Corp. II on its US$949 million business combination with BridgeBio Oncology Therapeutics

White & Case advises Merck KGaA on agreement to acquire life science company Mirus Bio for US$600 million

White & Case Advises Athyrium Capital Management on the Restructuring of RevitaLid Pharmaceutical Corp. and its Subsidiaries

White & Case advises Azurity Pharmaceuticals, Inc. on acquisition of Slayback Pharma, LLC

White & Case Advises Graf Acquisition Corp. IV on Business Combination with NkGen Biotech, Inc.

White & Case Advises Biosynex on Merger Agreement With Chembio Diagnostics, Inc.

White & Case Promotes 26 to Local Partner and 14 to Counsel

White & Case Advises Famy Life Sciences on Its Acquisition by Viatris Inc.

White & Case advises Apollomics Inc. on its US$899 million business combination with Maxpro Capital Acquisition Corp.

White & Case advises LOTTE Corporation on US$160 million acquisition of pharmaceutical manufacturing facility from Bristol Myers Squibb

White & Case Advises ADVANZ PHARMA on Acquisition of Intercept Pharmaceuticals

White & Case Advises Zimmer Biomet on Spinoff of ZimVie

White & Case Advises Soaring Eagle Acquisition Corp. on Its Business Combination with Ginkgo Bioworks

White & Case Advises QIA on Entrada Therapeutics Financing